Erythropoietin analogue
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Erythropoietin analogue, covering 2025-11-20 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: High Dose of Erythropoietin Analogue After Cardiac Arrest [Phase 3]